Orasis Pharmaceuticals Company

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Technology: Small Molecules
Industry: Geroscience
Headquarters: Herzliya, Tel Aviv, Israel
Founded Date: 2015-01-01
Employees Number: 1-10
Investors Number: 7
Total Funding: 43000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-09-10
Last Funding Type: Series C

Visit Website
info@orasis-pharma.com
https://www.orasis-pharma.com/
Register and Claim Ownership